Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update

    NEXT STORY
    Conformis, Inc. Announces Clearance in Australia for iTotal® PS, the Only Personalized, Posterior-Stabilized Total Knee Replacement System
    PREV STORY
    ChemoCentryx Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Highlights
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    eFFECTOR’s Zotatifin (eFT226) Downregulates Key Oncogenic Driver Proteins Including RTKs (HER2, FGFR1 and FGFR2) Providing Single Agent Activity and Key Combination Opportunities

    author_avatar
    NASDAQ Market News

    Adverum Biotechnologies Doses First Patient in the ADVANCE Phase 1/2 Clinical Trial of ADVM-043 for A1AT Deficiency

    -- Company Expects to Report Preliminary Data in the Second Half of 2018 -- ...

    author_avatar
    NASDAQ Market News

    BeyondSpring Provides Operational Updates and First-Quarter 2018 Financial Results

    NEW YORK, June 21, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (the Company) (NASDAQ:BYSI), a ...

    author_avatar
    NASDAQ Market News